ATE199395T1 - Tyrosinkinase - Google Patents

Tyrosinkinase

Info

Publication number
ATE199395T1
ATE199395T1 AT92915250T AT92915250T ATE199395T1 AT E199395 T1 ATE199395 T1 AT E199395T1 AT 92915250 T AT92915250 T AT 92915250T AT 92915250 T AT92915250 T AT 92915250T AT E199395 T1 ATE199395 T1 AT E199395T1
Authority
AT
Austria
Prior art keywords
tyrosine kinase
wild
strand break
dna double
break repair
Prior art date
Application number
AT92915250T
Other languages
English (en)
Inventor
Merl F Hoekstra
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Application granted granted Critical
Publication of ATE199395T1 publication Critical patent/ATE199395T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Radiography Using Non-Light Waves (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92915250T 1991-07-03 1992-07-01 Tyrosinkinase ATE199395T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72878391A 1991-07-03 1991-07-03
PCT/US1992/005565 WO1993001205A1 (en) 1991-07-03 1992-07-01 Tyrosine kinase

Publications (1)

Publication Number Publication Date
ATE199395T1 true ATE199395T1 (de) 2001-03-15

Family

ID=24928264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92915250T ATE199395T1 (de) 1991-07-03 1992-07-01 Tyrosinkinase

Country Status (8)

Country Link
US (1) US5705377A (de)
EP (1) EP0594710B1 (de)
JP (1) JPH06510664A (de)
AT (1) ATE199395T1 (de)
CA (1) CA2112748A1 (de)
DE (1) DE69231710T2 (de)
ES (1) ES2156860T3 (de)
WO (1) WO1993001205A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060296A (en) * 1991-07-03 2000-05-09 The Salk Institute For Biological Studies Protein kinases
CA2132452C (en) * 1993-01-21 2003-10-21 The Salk Institute For Biological Studies Casein kinase i-like protein kinase
US7590493B2 (en) 2000-07-31 2009-09-15 Ocimum Biosolutions, Inc. Methods for determining hepatotoxins
CA2447357A1 (en) 2001-05-22 2002-11-28 Gene Logic, Inc. Molecular toxicology modeling
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling

Also Published As

Publication number Publication date
DE69231710T2 (de) 2001-09-20
ES2156860T3 (es) 2001-08-01
EP0594710A4 (de) 1994-11-02
EP0594710B1 (de) 2001-02-28
US5705377A (en) 1998-01-06
CA2112748A1 (en) 1993-01-21
JPH06510664A (ja) 1994-12-01
DE69231710D1 (de) 2001-04-05
WO1993001205A1 (en) 1993-01-21
EP0594710A1 (de) 1994-05-04

Similar Documents

Publication Publication Date Title
DE69510410D1 (de) Proteinkinase
ATE408422T1 (de) Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten
FI950859A7 (fi) Arylideeni- ja heteroarylideeni-oksindolijohdannaiset tyrosiinikinaasi-inhibiittoreina
DE69942627D1 (de) Verstärkungs- und Pegelregelungen von optischen Verstärkern in Kaskade
LU91758I9 (de)
EP0608897A3 (en) Tyrosine kinase inhibitors and benzoylacrylamide derivatives.
AU2002343557A1 (en) Substituted aryl 1,4-pyrazine derivatives
FI973467A0 (fi) DNA-molekyylejä, valmistus ja käyttö geeniterapiassa
BR9607347A (pt) Esteres e amidas de 1,4-piperidina dissubstítuída possuindo atividade antagonística 5-ht
MX9709147A (es) Compuestos novedosos, preparacion y uso de los mismos.
IL129054A0 (en) Benzonaphthyridines as bronchial therapeutics
ATE227561T1 (de) Verwendung von alpha-alkylglucosiden und deren estern als antimikrobielle emulgatoren
DE69231710D1 (de) Tyrosinkinase
DE69727625D1 (de) Aufzeichnung von On-Line-Dokumenten
NZ326596A (en) Isolated vertebrate signalin gene peptide and use in intracellular signal transduction pathways mediated by TGF beta
AU2932100A (en) Neurodegenerative disorder related gene
NO990849D0 (no) Substituerte 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyklohepta (b) benzofuraner
ATE243036T1 (de) Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
DK0981644T3 (da) APC mutation, der står i forbindelse med familierelateret colorectal cancer hos Ashkenazi -jøder
WO1994017189A3 (en) Protein kinases
DE69130845D1 (de) HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung
DE69837808D1 (de) pRb2/p130 PEPTIDINHIBITOREN DER cdk2 KINASEAKTIVITÄT
BR0113266A (pt) Métodos para modular proteìnas quinase de linhagem múltipla e compostos protetores que modulam proteìnas quinase de linhagem múltipla
DE59000772D1 (de) Seitenstaendige carbazolyl-gruppen enthaltende methacrylat-(co)polymerisate und elektrophotographische aufzeichnungselemente, enthaltend dieselben.
ATE186731T1 (de) Anomere fluorribosylamine